Aveanna Healthcare Holdings Inc. $AVAH Shares Sold by Emerald Advisers LLC

Emerald Advisers LLC reduced its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 3.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,690,457 shares of the company’s stock after selling 58,268 shares during the period. Emerald Advisers LLC owned about 0.78% of Aveanna Healthcare worth $10,887,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Principal Financial Group Inc. purchased a new position in shares of Aveanna Healthcare during the first quarter worth $895,000. Hsbc Holdings PLC boosted its holdings in Aveanna Healthcare by 465.5% in the first quarter. Hsbc Holdings PLC now owns 76,029 shares of the company’s stock valued at $493,000 after purchasing an additional 62,584 shares during the last quarter. Summit Securities Group LLC purchased a new stake in Aveanna Healthcare in the first quarter valued at $53,000. Assenagon Asset Management S.A. boosted its holdings in Aveanna Healthcare by 16.4% in the first quarter. Assenagon Asset Management S.A. now owns 951,594 shares of the company’s stock valued at $6,128,000 after purchasing an additional 134,043 shares during the last quarter. Finally, Balboa Wealth Partners grew its position in Aveanna Healthcare by 63.7% during the 1st quarter. Balboa Wealth Partners now owns 27,657 shares of the company’s stock worth $178,000 after purchasing an additional 10,767 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $10.00 to $11.00 in a report on Friday, May 15th. Barclays raised their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a report on Thursday, July 9th. BMO Capital Markets lowered their price objective on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. Finally, Truist Financial increased their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $10.56.

Aveanna Healthcare Stock Down 0.3%

AVAH opened at $9.67 on Tuesday. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.73 and a twelve month high of $10.32. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. The company has a 50-day moving average price of $7.72 and a 200 day moving average price of $7.59. The company has a market cap of $2.11 billion, a PE ratio of 8.19, a price-to-earnings-growth ratio of 0.96 and a beta of 1.89.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm had revenue of $647.91 million for the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare’s quarterly revenue was up 15.9% compared to the same quarter last year. Sell-side analysts expect that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current fiscal year.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total value of $36,455,577.60. Following the transaction, the insider owned 13,450,547 shares in the company, valued at $83,931,413.28. This trade represents a 30.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total value of $43,680,000.00. Following the sale, the insider owned 252,899 shares of the company’s stock, valued at $1,578,089.76. The trade was a 96.51% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 31,305,664 shares of company stock worth $215,555,910 over the last three months. 5.30% of the stock is owned by insiders.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.